Aura Biosciences, Inc. (AURA) Operating cash flow 2020–2025
Aura Biosciences, Inc. (AURA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$84.7MFY2025 · since FY2020: -$24.3M → -$84.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.7M | -6.2% |
| FY2024 | -$79.8M | -25.0% |
| FY2023 | -$63.8M | -16.9% |
| FY2022 | -$54.6M | -68.5% |
| FY2021 | -$32.4M | -33.3% |
| FY2020 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice